+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Forecast 2024-2030- Product Image
Global Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Forecast 2024-2030- Product Image
Sale

Global Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336911
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac Biomarker Diagnostic Kits Market size was estimated at USD 3.78 billion in 2023, USD 4.11 billion in 2024, and is expected to grow at a CAGR of 8.93% to reach USD 6.88 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Biomarker Diagnostic Kits Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Biomarker Diagnostic Kits Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Biomarker Diagnostic Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Atlas Medical GmbH, Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Creative Diagnostics, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., LSI Medience Corporation, MP Biomedicals, LLC, PerkinElmer, Inc., Randox Laboratories Ltd., Siemens Healthcare GmbH, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Cardiac Biomarker Diagnostic Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease
    • Angina Pectoris
    • Cardiac Heart Failure
    • Myocardial Infraction
  • Testing
    • Laboratory Testing
    • Point of Care Testing
  • Product
    • BNP Test Kit
    • C-Reactive Protein
    • CK-MB Test Kits
    • Myoglobin Test Kits
    • Troponin Test Kits
  • End-User
    • Clinics
    • Diagnostics Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cardiac Biomarker Diagnostic Kits Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Biomarker Diagnostic Kits Market?
  3. What are the technology trends and regulatory frameworks in the Cardiac Biomarker Diagnostic Kits Market?
  4. What is the market share of the leading vendors in the Cardiac Biomarker Diagnostic Kits Market?
  5. Which modes and strategic moves are suitable for entering the Cardiac Biomarker Diagnostic Kits Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Biomarker Diagnostic Kits Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of cardiovascular diseases worldwide
5.1.1.2. Rising geriatric population and the consequent increase in the burden of chronic diseases
5.1.1.3. Growing consumer preference for early diagnosis and treatment
5.1.2. Restraints
5.1.2.1. Concerns related to sample collection and storage
5.1.3. Opportunities
5.1.3.1. Increase in R&D efforts for new developments
5.1.3.2. Growing trend of Point-of-care testing (POCT)
5.1.4. Challenges
5.1.4.1. Lack of supportive reimbursement policies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cardiac Biomarker Diagnostic Kits Market, by Disease
6.1. Introduction
6.2. Angina Pectoris
6.3. Cardiac Heart Failure
6.4. Myocardial Infraction
7. Cardiac Biomarker Diagnostic Kits Market, by Testing
7.1. Introduction
7.2. Laboratory Testing
7.3. Point of Care Testing
8. Cardiac Biomarker Diagnostic Kits Market, by Product
8.1. Introduction
8.2. BNP Test Kit
8.3. C-Reactive Protein
8.4. CK-MB Test Kits
8.5. Myoglobin Test Kits
8.6. Troponin Test Kits
9. Cardiac Biomarker Diagnostic Kits Market, by End-User
9.1. Introduction
9.2. Clinics
9.3. Diagnostics Centers
9.4. Hospitals
10. Americas Cardiac Biomarker Diagnostic Kits Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cardiac Biomarker Diagnostic Kits Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cardiac Biomarker Diagnostic Kits Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Atlas Medical GmbH
14.1.3. Beckman Coulter, Inc.
14.1.4. Becton, Dickinson, and Company
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. bioMérieux SA
14.1.7. Creative Diagnostics
14.1.8. DiaSorin S.p.A.
14.1.9. F. Hoffmann-La Roche Ltd.
14.1.10. Guangzhou Wondfo Biotech Co., Ltd.
14.1.11. Lepu Medical Technology (Beijing) Co., Ltd.
14.1.12. LSI Medience Corporation
14.1.13. MP Biomedicals, LLC
14.1.14. PerkinElmer, Inc.
14.1.15. Randox Laboratories Ltd.
14.1.16. Siemens Healthcare GmbH
14.1.17. Thermo Fisher Scientific, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET DYNAMICS
FIGURE 7. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 8. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
FIGURE 10. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CARDIAC HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOCARDIAL INFRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 10. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 13. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY BNP TEST KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CK-MB TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY MYOGLOBIN TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TROPONIN TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 36. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 37. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 41. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. MEXICO CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 58. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 59. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CHINA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 62. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 63. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 71. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. JAPAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 95. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. THAILAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 108. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. DENMARK CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 112. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. EGYPT CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 116. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FINLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 131. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 132. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. ITALY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 144. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. NORWAY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 147. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 148. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. POLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 151. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 152. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. QATAR CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 180. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. TURKEY CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 191. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Atlas Medical GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Creative Diagnostics
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LSI Medience Corporation
  • MP Biomedicals, LLC
  • PerkinElmer, Inc.
  • Randox Laboratories Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.88 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030 - Product Image

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028 - Product Image

Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028

  • Report
  • 216 Pages
  • Global
From
Global Cardiac Biomarker Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Cardiac Biomarker Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 192 Pages
  • Global
From
Cardiac Biomarker Diagnostic Test Kits Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cardiac Biomarker Diagnostic Test Kits Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 - Product Image

Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.